Anthony D'Adamio - 01 Apr 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
SVP & General Counsel
Signature
/s/ Anthony D'Adamio
Issuer symbol
BVS
Transactions as of
01 Apr 2022
Net transactions value
-$179,238
Form type
4
Filing time
05 Apr 2022, 21:16:44 UTC
Previous filing
12 Apr 2023
Next filing
22 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Options Exercise +37,476 +201% 56,148 01 Apr 2022 Direct F1
transaction BVS Class A Common Stock Sale $179,238 -16,016 -29% $11.19 40,132 04 Apr 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Options Exercise $0 -37,476 -100% $0.000000* 0 01 Apr 2022 Class A Common Stock 37,476 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2 Reflects shares sold to cover taxes upon the vesting of RSUs on April 1, 2022 pursuant to a standing 10b5-1 instruction.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.0438 to $11.54, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4 The RSUs vested on April 1, 2022.